Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Alzheimers Dis ; 47(2): 453-66, 2015.
Article in English | MEDLINE | ID: mdl-26401567

ABSTRACT

Numerous studies have shown that amyloid-ß (Aß) modulate intracellular metabolic cascades and an intracellular Ca2+ homeostasis and a cell surface NMDA receptor expression alteration in Alzheimer's disease (AD). However most of these findings have been obtained by using non-physiological Aß concentrations. The present study deals with the effect of low Aß concentrations on cellular homeostasis. We used nerve growth factor-differentiated PC12 cells and murine cortical neurons sequentially treated with low chronic monomeric or small oligomeric Aß concentrations and high acute oligomeric Aß concentrations to bring out a priming effect of chronic treatment on subsequently high Aß concentrations-elicited cellular response. Both cell types indeed displayed an enhanced capacity to bind oligomeric Aß after monomeric or small oligomeric Aß application. Furthermore, the results show that monomeric Aß1-42 application to the cells induces an increase of the Ca2+-response and of the membrane expression of the extrasynaptic subunit of the NMDA receptor GluN2B in PC12 cells, while the opposite effects were observed in cultured neurons. This suggests a sequential interaction of Aß with the cellular plasma membrane involving monomers or small Aß oligomers which would facilitate the binding of the deleterious high molecular Aß oligomers. This mechanism would explain the slow progression of AD in the human nervous system and the deep gradient of neuronal death observed around the amyloid plaques in the nervous tissue.


Subject(s)
Amyloid beta-Peptides/metabolism , Cell Membrane/metabolism , Peptide Fragments/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Blotting, Far-Western , Calcium/metabolism , Cerebral Cortex/metabolism , Cholera Toxin , Electrophoresis, Polyacrylamide Gel , Immunohistochemistry , Mice, Inbred C57BL , Neurons/metabolism , PC12 Cells , Rats , Thy-1 Antigens/metabolism , Voltage-Sensitive Dye Imaging
2.
Front Behav Neurosci ; 8: 446, 2014.
Article in English | MEDLINE | ID: mdl-25620921

ABSTRACT

Owing to a similar cerebral neuro-anatomy, non-human primates are viewed as the most valid models for understanding cognitive deficits. This study evaluated psychomotor and mnesic functions of 41 young to old mouse lemurs (Microcebus murinus). Psychomotor capacities and anxiety-related behaviors decreased abruptly from middle to late adulthood. However, mnesic functions were not affected in the same way with increasing age. While results of the spontaneous alternation task point to a progressive and widespread age-related decline of spatial working memory, both spatial reference and novel object recognition (NOR) memory tasks did not reveal any tendency due to large inter-individual variability in the middle-aged and old animals. Indeed, some of the aged animals performed as well as younger ones, whereas some others had bad performances in the Barnes maze and in the object recognition test. Hierarchical cluster analysis revealed that declarative-like memory was strongly impaired only in 7 out of 25 middle-aged/old animals. These results suggest that this analysis allows to distinguish elder populations of good and bad performers in this non-human primate model and to closely compare this to human aging.

3.
PLoS One ; 5(9)2010 Sep 30.
Article in English | MEDLINE | ID: mdl-20941361

ABSTRACT

Epsilon toxin (ET) produced by C. perfringens types B and D is a highly potent pore-forming toxin. ET-intoxicated animals express severe neurological disorders that are thought to result from the formation of vasogenic brain edemas and indirect neuronal excitotoxicity. The cerebellum is a predilection site for ET damage. ET has been proposed to bind to glial cells such as astrocytes and oligodendrocytes. However, the possibility that ET binds and attacks the neurons remains an open question. Using specific anti-ET mouse polyclonal antibodies and mouse brain slices preincubated with ET, we found that several brain structures were labeled, the cerebellum being a prominent one. In cerebellar slices, we analyzed the co-staining of ET with specific cell markers, and found that ET binds to the cell body of granule cells, oligodendrocytes, but not astrocytes or nerve endings. Identification of granule cells as neuronal ET targets was confirmed by the observation that ET induced intracellular Ca(2+) rises and glutamate release in primary cultures of granule cells. In cultured cerebellar slices, whole cell patch-clamp recordings of synaptic currents in Purkinje cells revealed that ET greatly stimulates both spontaneous excitatory and inhibitory activities. However, pharmacological dissection of these effects indicated that they were only a result of an increased granule cell firing activity and did not involve a direct action of the toxin on glutamatergic nerve terminals or inhibitory interneurons. Patch-clamp recordings of granule cell somata showed that ET causes a decrease in neuronal membrane resistance associated with pore-opening and depolarization of the neuronal membrane, which subsequently lead to the firing of the neuronal network and stimulation of glutamate release. This work demonstrates that a subset of neurons can be directly targeted by ET, suggesting that part of ET-induced neuronal damage observed in neuronal tissue is due to a direct effect of ET on neurons.


Subject(s)
Bacterial Toxins/pharmacology , Cerebellum/cytology , Cerebellum/drug effects , Glutamic Acid/metabolism , Neurons/drug effects , Animals , Bacterial Toxins/metabolism , Cells, Cultured , Cerebellum/metabolism , Clostridium Infections/metabolism , Clostridium Infections/microbiology , Clostridium perfringens/chemistry , Clostridium perfringens/metabolism , Humans , Mice , Mice, Inbred C57BL , Neurons/metabolism , Purkinje Cells/drug effects , Purkinje Cells/metabolism
4.
Exp Gerontol ; 45(1): 64-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19895879

ABSTRACT

Numerous studies have been performed, which assess an important role of protein kinase C (PKC) in the physiopathology of Alzheimer disease (AD). The alteration of PKC activity stimulates amyloid-beta peptides production and protein tau hyperphosphorylation. This recently led to consider PKC as a potential therapeutic target for disease modifying drugs. Moreover PKC alterations were also observed in peripheral cells including blood cells. This short review recalls the main findings on the role of PKC in the disease process and focuses on its use as an AD biomarker in blood cells. Using fluorescent probes specific for PKC, it is possible to detect the conformational changes of the enzyme in living cells. Such probes can be used to detect PKC alterations in red blood cells and thus to distinguish AD patients from healthy controls with unmatched specificity and sensitivity.


Subject(s)
Alzheimer Disease/diagnosis , Alzheimer Disease/metabolism , Biomarkers/metabolism , Erythrocytes/metabolism , Protein Kinase C/metabolism , Aged , Humans
5.
PLoS One ; 4(2): e4501, 2009.
Article in English | MEDLINE | ID: mdl-19225567

ABSTRACT

BACKGROUND: Antimicrobial peptides derived from the natural processing of chromogranin A (CgA) are co-secreted with catecholamines upon stimulation of chromaffin cells. Since PMNs play a central role in innate immunity, we examine responses by PMNs following stimulation by two antimicrobial CgA-derived peptides. METHODOLOGY/PRINCIPAL FINDINGS: PMNs were treated with different concentrations of CgA-derived peptides in presence of several drugs. Calcium mobilization was observed by using flow cytometry and calcium imaging experiments. Immunocytochemistry and confocal microscopy have shown the intracellular localization of the peptides. The calmodulin-binding and iPLA2 activating properties of the peptides were shown by Surface Plasmon Resonance and iPLA2 activity assays. Finally, a proteomic analysis of the material released after PMNs treatment with CgA-derived peptides was performed by using HPLC and Nano-LC MS-MS. By using flow cytometry we first observed that after 15 s, in presence of extracellular calcium, Chromofungin (CHR) or Catestatin (CAT) induce a concentration-dependent transient increase of intracellular calcium. In contrast, in absence of extra cellular calcium the peptides are unable to induce calcium depletion from the stores after 10 minutes exposure. Treatment with 2-APB (2-aminoethoxydiphenyl borate), a store operated channels (SOCs) blocker, inhibits completely the calcium entry, as shown by calcium imaging. We also showed that they activate iPLA2 as the two CaM-binding factors (W7 and CMZ) and that the two sequences can be aligned with the two CaM-binding domains reported for iPLA2. We finally analyzed by HPLC and Nano-LC MS-MS the material released by PMNs following stimulation by CHR and CAT. We characterized several factors important for inflammation and innate immunity. CONCLUSIONS/SIGNIFICANCE: For the first time, we demonstrate that CHR and CAT, penetrate into PMNs, inducing extracellular calcium entry by a CaM-regulated iPLA2 pathway. Our study highlights the role of two CgA-derived peptides in the active communication between neuroendocrine and immune systems.


Subject(s)
Calmodulin/metabolism , Chromogranin A/pharmacology , Neutrophils/drug effects , Peptide Fragments/pharmacology , Phospholipases A2, Calcium-Independent/metabolism , Calcium Signaling , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Neutrophils/metabolism , Proteins/metabolism , Proteomics
6.
J Biol Chem ; 284(8): 4836-45, 2009 Feb 20.
Article in English | MEDLINE | ID: mdl-19124467

ABSTRACT

An important role for specific lipids in membrane fusion has recently emerged, but regulation of their biosynthesis remains poorly understood. Among fusogenic lipids, phosphatidic acid and phosphoinositol 4,5-bisphosphate (PIP(2)) have been proposed to act at various steps of neurotransmitter and hormone exocytosis. Using real time FRET (fluorescence resonance energy transfer) measurements, we show here that the GTPase ARF6, potentially involved in the synthesis of these lipids, is activated at the exocytotic sites in PC12 cells stimulated for secretion. Depletion of endogenous ARF6 by siRNA dramatically inhibited secretagogue-evoked exocytosis. ARF6-siRNA greatly reduced secretagogue-evoked phospholipase D (PLD) activation and phosphatidic acid formation at the plasma membrane and moderately reduced constitutive levels of PIP(2) present at the plasma membrane in resting cells. Expression of an ARF6 insensitive to short interference RNA (siRNA) fully rescued secretion in ARF6-depleted cells. However, a mutated ARF6 protein specifically impaired in its ability to stimulate PLD had no effect. Finally, we show that the ARF6-siRNA-mediated inhibition of exocytosis could be rescued by an exogenous addition of lysophosphatidylcholine, a lipid that favors negative curvature on the inner leaflet of the plasma membrane. Altogether these data indicate that ARF6 is a critical upstream signaling element in the activation of PLD necessary to produce the fusogenic lipids required for exocytosis.


Subject(s)
ADP-Ribosylation Factors/metabolism , Calcium/metabolism , Exocytosis/physiology , Neuroendocrine Cells/metabolism , Phosphatidic Acids/biosynthesis , Phosphatidylinositol 4,5-Diphosphate/biosynthesis , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/antagonists & inhibitors , Animals , Cell Membrane/enzymology , Enzyme Activation/drug effects , Enzyme Activation/physiology , Fluorescence Resonance Energy Transfer , Neuroendocrine Cells/cytology , PC12 Cells , Phospholipase D/metabolism , RNA, Small Interfering/pharmacology , Rats , Signal Transduction/drug effects , Signal Transduction/physiology
7.
J Nat Prod ; 70(8): 1329-34, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17663584

ABSTRACT

Bioassay-guided fractionation, combined with screening based on EGF-responsive neural stem cells (NSCs) differentiation assay, has been used to search for active molecules from Panax notoginseng. Ginsenosides Rg3 (1), Rk1 (2), and Rg5 (3) were identified as potential neurogenic molecules. The degrees of their neurogenic effects were found to be 3 > 2 > 1. The neurogenic effect of 3 represents a biphasic dose- and time-dependent regulation. Transient exposure of NSCs to 8 microM 3 for 24 h followed by 1 microM and 72 h incubation was the optimal procedure for the induction of neurons in NSCs, and compound 3 resulted in an approximately 3-fold increase in neurogenesis at the expense of astrogliogenesis. The neurogenic effect of 3 was completely eliminated by the Ca2+ channel antagonist nifedipine. These findings imply that 3 may be utilized as a pharmacological agent in studying the molecular regulation of neurogenesis of brain stem cells and, subsequently, for treatment of neurodegenerative diseases.


Subject(s)
Drugs, Chinese Herbal/isolation & purification , Drugs, Chinese Herbal/pharmacology , Ginsenosides/isolation & purification , Ginsenosides/pharmacology , Glycosides/isolation & purification , Glycosides/pharmacology , Neurons/drug effects , Panax notoginseng/chemistry , Plants, Medicinal/chemistry , Stem Cells/drug effects , Triterpenes/isolation & purification , Triterpenes/pharmacology , Brain Stem/cytology , Calcium Channel Blockers/pharmacology , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/chemistry , Epidermal Growth Factor/metabolism , Ginsenosides/chemistry , Glycosides/chemistry , Molecular Structure , Neurodegenerative Diseases/etiology , Neurodegenerative Diseases/therapy , Nifedipine/pharmacology , Time Factors , Triterpenes/chemistry
8.
J Biol Chem ; 281(26): 18098-111, 2006 Jun 30.
Article in English | MEDLINE | ID: mdl-16638749

ABSTRACT

Several studies have shown that the neuronal calcium sensor (NCS-1) and phosphoinositol 4-kinase-beta (PI4K-beta) regulate the exocytotic process of nerve and neuroendocrine cells. The aim of our study was to investigate their possible interaction at rest and during stimulation in living cells and to decipher the role of this interaction in the secretory process. In PC12 cells, we observed a stimulation-induced recruitment of NCS-1 and PI4K-beta from the intracellular compartment toward the plasma membrane. This recruitment was highly correlated to the intracellular Ca(2+) rise induced by secretagogues. Using fluorescence resonance energy transfer between PI4K-beta-ECFP and NCS-1-EYFP, we show that both proteins are interacting in resting cells and that this interaction increases with stimulation. It appears that the membrane insertion of NCS-1 is necessary for the interaction with PI4K-beta, since a mutation that prevented the membrane insertion of NCS-1 abolished NCS-1-PI4K-beta interaction, as revealed by fluorescence resonance energy transfer analysis. Additionally, the overexpression of mutated NCS-1 prevents the stimulatory effect on secretion induced by PI4K-beta, suggesting that the interaction of the two proteins on a membrane compartment is necessary for the secretory function. Moreover, extinction of endogenous PI4K-beta by small interfering RNA inhibits secretion and completely prevents the stimulatory effect of NCS-1 on calcium-evoked exocytosis from permeabilized PC12 cells, showing directly for the first time the functional implication of a NCS-1.PI4K-beta complex in regulated exocytosis.


Subject(s)
1-Phosphatidylinositol 4-Kinase/metabolism , Calcium-Binding Proteins/metabolism , Exocytosis/physiology , Neurons/metabolism , Neuropeptides/metabolism , 1-Phosphatidylinositol 4-Kinase/genetics , Animals , Calcium/metabolism , Calcium-Binding Proteins/genetics , Cytoplasm/metabolism , Electric Stimulation , Gene Expression , Neuronal Calcium-Sensor Proteins , Neurons/cytology , Neuropeptides/genetics , PC12 Cells , Rats , Secretory Vesicles/physiology
9.
Neurobiol Aging ; 27(2): 245-51, 2006 Feb.
Article in English | MEDLINE | ID: mdl-15893856

ABSTRACT

There is a growing evidence of early changes of blood cells in Alzheimer's disease (AD). We have developed an original novel method for quantifying the alteration of protein kinase C (PKC) by its fluorescence spectrum: by using Fim-1, a specific fluorescent probe made for protein kinase C that detects the conformational changes of this. We show that the PKC conformation is altered in red blood cells (RBC) from AD patients as compared to RBC from healthy controls. This alteration is independent of the patient's age and of the stage of the disease. It is not observed in the RBC of non-demented patients suffering from Parkinson's disease (PD). If PKC alteration is proven to be specific to AD as compared with other dementia, this method could be for a simple, low cost screening test among patients suspected of having AD and may have a strong predictive value.


Subject(s)
Alzheimer Disease/blood , Erythrocytes/metabolism , Protein Kinase C/chemistry , Age Factors , Aged , Analysis of Variance , Biomarkers , Enzyme Inhibitors/pharmacology , Erythrocytes/drug effects , Female , Fluoresceins , Humans , Indoles , Male , Parkinson Disease/blood , Phorbol Esters/pharmacology , Protein Conformation , Protein Kinase C/blood , Spectrum Analysis/methods , Staurosporine/pharmacology
10.
Exp Cell Res ; 289(2): 222-36, 2003 Oct 01.
Article in English | MEDLINE | ID: mdl-14499623

ABSTRACT

Actin is a major substrate for protein kinase C (PKC) and PKC is considered a modulator of the actin network. In addition in vitro studies (Biochemistry 39 (2000) 271) have suggested that all PKC isoforms bind to actin during the process of activation of the enzyme. To test the physiological significance of such a coupling we used living PC12 cells and primary cultures of cerebellar granule cells. When PC12 cells were treated with either latrunculin B, which impairs actin polymerization, or phalloidin, which stabilizes actin filaments, we observed a significant reduction of the [Ca2+]i response revealed by Fura-2 fluorescence, while the PKC conformational changes followed by Fim-1 fluorescence were unaffected. The responses induced either by cell depolarization or muscarinic receptor activation were similarly affected by the toxin treatment of PC12 cells. In cerebellar granule cells the [Ca2+]i response induced by KCl depolarization was increased by latrunculin treatment, whereas no effect was observed on the PKC response. Latrunculin had no effect on the NMDA-induced responses in these cells. Finally we also show that the response induced by a long-lasting depolarization, which mimics stimulation leading to neuronal plasticity, was not significantly altered by latrunculin or phalloidin treatment of the cells. These results suggest that the actin network is not involved in the initial steps of the PKC activation process in living nerve cells.


Subject(s)
Actin Cytoskeleton/metabolism , Actins/metabolism , Cytoskeleton/enzymology , Neurons/enzymology , Protein Kinase C/metabolism , Actin Cytoskeleton/drug effects , Animals , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Calcium/metabolism , Calcium Signaling/drug effects , Calcium Signaling/physiology , Cytoskeleton/drug effects , Immunohistochemistry , Molecular Conformation , Neurons/drug effects , PC12 Cells , Phalloidine/pharmacology , Potassium Chloride/pharmacology , Protein Isoforms/drug effects , Protein Isoforms/metabolism , Protein Kinase C/drug effects , Rats , Thiazoles/pharmacology , Thiazolidines
11.
Eur J Neurosci ; 3(11): 1146-1154, 1991 Oct.
Article in English | MEDLINE | ID: mdl-12106244

ABSTRACT

Using primary rat cerebellar cell cultures we observed that trans-1-amino-cyclopentyl-1,3-dicarboxylic acid (t-ACPD) was able to induce an increase in intracellular [Ca2+] in different cell types. This response was not abolished by external Ca2+ withdrawal, indicating that t-ACPD triggered the release of intracellularly stored Ca2+. In neurons the t-ACPD response was monophasic and inhibited by l-2-amino-4-phosphonobutyrate (APB). In astrocytes, characterized by their immunoreactivity to antisera to glial fibrillary acidic protein and S-100 protein, the response was oscillatory and resistant to APB application. These results suggest the presence of glutamate metabotropic receptor subtypes in the mammalian brain.

SELECTION OF CITATIONS
SEARCH DETAIL
...